In vitro

Global In-Vitro Diagnostics Market 2018-2027 - Impact of COVID-19, Key Trends & Developments, Competitive Landscape

Wednesday, May 27, 2020 - 1:15pm

DUBLIN, May 27, 2020 /PRNewswire/ -- The "In Vitro Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 27, 2020 /PRNewswire/ -- The "In Vitro Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global In Vitro Diagnostics market accounted for $87.9 billion in 2018 and is expected to reach $164.4 billion by 2027, growing at a CAGR of 7.2% during the forecast period.
  • Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth.
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
    Company profiling with detailed strategies, financials, and recent developments

Outlook on the Worldwide In Vitro Fertilization Market to 2024 - Promising High-growth Opportunities - ResearchAndMarkets.com

Wednesday, May 27, 2020 - 1:50pm

The global in vitro fertilization market is expected to grow with a CAGR of 11% from 2019 to 2024.

Key Points: 
  • The global in vitro fertilization market is expected to grow with a CAGR of 11% from 2019 to 2024.
  • The study includes the in vitro fertilization market size and forecast for the global in vitro fertilization market through 2024, segmented by type of cycles, instrument, product, end user, and the region.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions for in vitro fertilization in the global in vitro fertilization market.
  • Strategic analysis: This includes M&A, new product development, and competitive landscape for, in vitro fertilization in the global in vitro fertilization market.

In Vitro Diagnostics Market Assessment and Forecast to 2027 - ResearchAndMarkets.com

Monday, May 25, 2020 - 2:13pm

The "In Vitro Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In Vitro Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global In Vitro Diagnostics market accounted for $87.9 billion in 2018 and is expected to reach $164.4 billion by 2027, growing at a CAGR of 7.2% during the forecast period.
  • Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth.
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
    Company profiling with detailed strategies, financials, and recent developments

Atossa Therapeutics Announces Successful In vitro Testing Results of COVID-19 Drug: AT-H201 Inhibits SARS-CoV-2 Infectivity of VERO Cells in Laboratory Culture

Wednesday, May 20, 2020 - 2:30pm

The preliminary study results show that AT-H201 inhibits SARS-CoV-2 infectivity of VERO cells in a laboratory culture, which are the standard cell types being used to study infectivity of the coronavirus.

Key Points: 
  • The preliminary study results show that AT-H201 inhibits SARS-CoV-2 infectivity of VERO cells in a laboratory culture, which are the standard cell types being used to study infectivity of the coronavirus.
  • Significant findings from the testing include:
    AT-H201 components inhibited SARS-CoV-2 from infecting VERO cells in a laboratory culture.
  • Potency was measured by microscopic examination of the cytopathic effect caused by SARS-CoV-2 in VERO cells.
  • Successful in vitro tests do not guarantee similar results from in vivo studies, including in human clinical trials.

In Vitro Diagnostics (IVD) Partnering Deals, Worldwide, 2014-2020 - Access to Headline, Upfront, Milestone and Royalty Data

Thursday, May 14, 2020 - 7:45pm

This report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals.

Key Points: 
  • This report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals.
  • Insight into terms included in a In Vitro Diagnostics partnering agreement, with real world examples
    The report takes the reader through a comprehensive review In Vitro Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering In Vitro Diagnostics partnering deals.
  • Chapter 2 provides an overview of the trends in In Vitro Diagnostics dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.
  • Chapter 6 provides a comprehensive and detailed review of In Vitro Diagnostics partnering deals signed and announced since Jan 2014.

Global In Vitro Diagnostics Partnering Deals Collection 2014-2020 - ResearchAndMarkets.com

Thursday, May 14, 2020 - 2:07pm

The "Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering.
  • This report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals.
  • Insight into terms included in a In Vitro Diagnostics partnering agreement, with real world examples
    The report takes the reader through a comprehensive review In Vitro Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering In Vitro Diagnostics partnering deals.
  • Chapter 6 provides a comprehensive and detailed review of In Vitro Diagnostics partnering deals signed and announced since Jan 2014.

In-Vitro Diagnostic (IVD) Markets 2020: Analysis, COVID-19, AI, Companies

Wednesday, May 13, 2020 - 11:15pm

DUBLIN, May 13, 2020 /PRNewswire/ -- The "Artificial Intelligence Markets in IVD" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 13, 2020 /PRNewswire/ -- The "Artificial Intelligence Markets in IVD" report has been added to ResearchAndMarkets.com's offering.
  • This report examines selected AI-based initiatives, collaborations, and tests in various in vitro diagnostic (IVD) market segments.
  • More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development.
  • In recent years, diagnostics companies - in collaboration with AI companies - have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care.

COVID-19 Impact on IVD (In Vitro Diagnostics) Market - Exclusive Report by MarketsandMarkets™

Wednesday, May 6, 2020 - 4:00pm

The US is expected to account for the largest share of the in-vitro diagnostics market in 2020, followed by Europe.

Key Points: 
  • The US is expected to account for the largest share of the in-vitro diagnostics market in 2020, followed by Europe.
  • Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".
  • MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments.

COVID-19 Impact on IVD (In Vitro Diagnostics) Market - Exclusive Report by MarketsandMarkets™

Wednesday, May 6, 2020 - 4:00pm

The US is expected to account for the largest share of the in-vitro diagnostics market in 2020, followed by Europe.

Key Points: 
  • The US is expected to account for the largest share of the in-vitro diagnostics market in 2020, followed by Europe.
  • Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".
  • MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments.

SG Blocks Signs Agreement With OSANG Healthcare to Distribute COVID-19 Rapid Tests in U.S. Under OSANG’s FDA Emergency Use Authorization

Tuesday, May 5, 2020 - 11:00am

As we strive to return to normal life, it is critical to free up hospitals to perform normal duties again.

Key Points: 
  • As we strive to return to normal life, it is critical to free up hospitals to perform normal duties again.
  • Our pipeline is substantial, and SG Blocks has the ability to address logistical challenges utilizing their modular construction expertise.
  • OSANG Healthcare is a South Korea based global manufacturer and distributor of medical devices and in-vitro diagnostics solutions.
  • Each project starts with GreenSteel, the structural core and shell of an SG Blocks building, and then customized to client specifications.